APO Research
Talk to an analyst

APO RESEARCH · REPORT

Mercaptopurine Tablets

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Mercaptopurine Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

23 December 2025198 pages

Choose your research edition.

Industry ResearchMercaptopurine Tablets Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Mercaptopurine Tablets Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Mercaptopurine Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Mercaptopurine Tablets Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Mercaptopurine Tablets Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Mercaptopurine Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Mercaptopurine Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Mercaptopurine Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Mercaptopurine Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Mercaptopurine Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Mercaptopurine Tablets include Zhejiang Zhebei Pharmaceutical, Sinopharm, Shaanxi Hantang Pharmaceutical, China Resources Double-Crane Pharmaceutical, Zhejiang Hisun Pharmaceutical, Guangzhou Baiyunshan Guanghua Pharmaceutical, Viatris, Stason Pharmaceuticals and Hikma Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Mercaptopurine Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Mercaptopurine Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Mercaptopurine Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Mercaptopurine Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Mercaptopurine Tablets Segment by Company

Zhejiang Zhebei Pharmaceutical

Sinopharm

Shaanxi Hantang Pharmaceutical

China Resources Double-Crane Pharmaceutical

Zhejiang Hisun Pharmaceutical

Guangzhou Baiyunshan Guanghua Pharmaceutical

Viatris

Stason Pharmaceuticals

Hikma Pharmaceuticals

Dr. Reddy's Laboratories

Mercaptopurine Tablets Segment by Type

25mg

50mg

Mercaptopurine Tablets Segment by Application

Hospital

Clinic

Others

Mercaptopurine Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mercaptopurine Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Mercaptopurine Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mercaptopurine Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Mercaptopurine Tablets market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Mercaptopurine Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Mercaptopurine Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Mercaptopurine Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Mercaptopurine Tablets Industry Trends Table 2. Mercaptopurine Tablets Industry Drivers Table 3. Mercaptopurine Tablets Industry Opportunities and Challenges Table 4. Mercaptopurine Tablets Industry Restraints Table 5. Global Mercaptopurine Tablets Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Mercaptopurine Tablets Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Mercaptopurine Tablets Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Mercaptopurine Tablets Sales Market Share by Manufacturers Table 9. Global Mercaptopurine Tablets Average Sales Price (USD/unit) of Manufacturers (2021-2026) Table 10. Global Mercaptopurine Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Mercaptopurine Tablets Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Mercaptopurine Tablets Manufacturers, Product Type & Application Table 13. Global Mercaptopurine Tablets Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Mercaptopurine Tablets by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 25mg Table 17. Major Manufacturers of 50mg Table 18. Global Mercaptopurine Tablets Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Mercaptopurine Tablets Sales by Type (2021-2026) & (k units) Table 20. Global Mercaptopurine Tablets Sales by Type (2027-2032) & (k units) Table 21. Global Mercaptopurine Tablets Sales Market Share by Type (2021-2026) Table 22. Global Mercaptopurine Tablets Sales Market Share by Type (2027-2032) Table 23. Global Mercaptopurine Tablets Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Mercaptopurine Tablets Revenue by Type (2021-2026) & (k units) Table 25. Global Mercaptopurine Tablets Revenue by Type (2027-2032) & (k units) Table 26. Global Mercaptopurine Tablets Revenue Market Share by Type (2021-2026) Table 27. Global Mercaptopurine Tablets Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Clinic Table 30. Major Manufacturers of Others Table 31. Global Mercaptopurine Tablets Sales by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Mercaptopurine Tablets Sales by Application (2021-2026) & (k units) Table 33. Global Mercaptopurine Tablets Sales by Application (2027-2032) & (k units) Table 34. Global Mercaptopurine Tablets Sales Market Share by Application (2021-2026) Table 35. Global Mercaptopurine Tablets Sales Market Share by Application (2027-2032) Table 36. Global Mercaptopurine Tablets Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global Mercaptopurine Tablets Revenue by Application (2021-2026) & (k units) Table 38. Global Mercaptopurine Tablets Revenue by Application (2027-2032) & (k units) Table 39. Global Mercaptopurine Tablets Revenue Market Share by Application (2021-2026) Table 40. Global Mercaptopurine Tablets Revenue Market Share by Application (2027-2032) Table 41. Global Mercaptopurine Tablets Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Mercaptopurine Tablets Sales by Region (2021-2026) & (k units) Table 43. Global Mercaptopurine Tablets Sales Market Share by Region (2021-2026) Table 44. Global Mercaptopurine Tablets Sales Forecasted by Region (2027-2032) & (k units) Table 45. Global Mercaptopurine Tablets Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Mercaptopurine Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 47. North America Mercaptopurine Tablets Sales by Country (2021-2026) & (k units) Table 48. North America Mercaptopurine Tablets Sales by Country (2027-2032) & (k units) Table 49. Europe Mercaptopurine Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. Europe Mercaptopurine Tablets Sales by Country (2021-2026) & (k units) Table 51. Europe Mercaptopurine Tablets Sales by Country (2027-2032) & (k units) Table 52. Asia Pacific Mercaptopurine Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Asia Pacific Mercaptopurine Tablets Sales by Country (2021-2026) & (k units) Table 54. Asia Pacific Mercaptopurine Tablets Sales by Country (2027-2032) & (k units) Table 55. South America, Middle East and Africa Mercaptopurine Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. South America, Middle East and Africa Mercaptopurine Tablets Sales by Country (2021-2026) & (k units) Table 57. South America, Middle East and Africa Mercaptopurine Tablets Sales by Country (2027-2032) & (k units) Table 58. Global Mercaptopurine Tablets Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Mercaptopurine Tablets Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Mercaptopurine Tablets Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Mercaptopurine Tablets Revenue Market Share by Region (2021-2026) Table 62. Global Mercaptopurine Tablets Revenue Market Share by Region (2027-2032) Table 63. Zhejiang Zhebei Pharmaceutical Company Information Table 64. Zhejiang Zhebei Pharmaceutical Business Overview Table 65. Zhejiang Zhebei Pharmaceutical Mercaptopurine Tablets Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Zhejiang Zhebei Pharmaceutical Mercaptopurine Tablets Product Portfolio Table 67. Zhejiang Zhebei Pharmaceutical Recent Development Table 68. Sinopharm Company Information Table 69. Sinopharm Business Overview Table 70. Sinopharm Mercaptopurine Tablets Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Sinopharm Mercaptopurine Tablets Product Portfolio Table 72. Sinopharm Recent Development Table 73. Shaanxi Hantang Pharmaceutical Company Information Table 74. Shaanxi Hantang Pharmaceutical Business Overview Table 75. Shaanxi Hantang Pharmaceutical Mercaptopurine Tablets Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Shaanxi Hantang Pharmaceutical Mercaptopurine Tablets Product Portfolio Table 77. Shaanxi Hantang Pharmaceutical Recent Development Table 78. China Resources Double-Crane Pharmaceutical Company Information Table 79. China Resources Double-Crane Pharmaceutical Business Overview Table 80. China Resources Double-Crane Pharmaceutical Mercaptopurine Tablets Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. China Resources Double-Crane Pharmaceutical Mercaptopurine Tablets Product Portfolio Table 82. China Resources Double-Crane Pharmaceutical Recent Development Table 83. Zhejiang Hisun Pharmaceutical Company Information Table 84. Zhejiang Hisun Pharmaceutical Business Overview Table 85. Zhejiang Hisun Pharmaceutical Mercaptopurine Tablets Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Zhejiang Hisun Pharmaceutical Mercaptopurine Tablets Product Portfolio Table 87. Zhejiang Hisun Pharmaceutical Recent Development Table 88. Guangzhou Baiyunshan Guanghua Pharmaceutical Company Information Table 89. Guangzhou Baiyunshan Guanghua Pharmaceutical Business Overview Table 90. Guangzhou Baiyunshan Guanghua Pharmaceutical Mercaptopurine Tablets Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Guangzhou Baiyunshan Guanghua Pharmaceutical Mercaptopurine Tablets Product Portfolio Table 92. Guangzhou Baiyunshan Guanghua Pharmaceutical Recent Development Table 93. Viatris Company Information Table 94. Viatris Business Overview Table 95. Viatris Mercaptopurine Tablets Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Viatris Mercaptopurine Tablets Product Portfolio Table 97. Viatris Recent Development Table 98. Stason Pharmaceuticals Company Information Table 99. Stason Pharmaceuticals Business Overview Table 100. Stason Pharmaceuticals Mercaptopurine Tablets Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Stason Pharmaceuticals Mercaptopurine Tablets Product Portfolio Table 102. Stason Pharmaceuticals Recent Development Table 103. Hikma Pharmaceuticals Company Information Table 104. Hikma Pharmaceuticals Business Overview Table 105. Hikma Pharmaceuticals Mercaptopurine Tablets Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Hikma Pharmaceuticals Mercaptopurine Tablets Product Portfolio Table 107. Hikma Pharmaceuticals Recent Development Table 108. Dr. Reddy's Laboratories Company Information Table 109. Dr. Reddy's Laboratories Business Overview Table 110. Dr. Reddy's Laboratories Mercaptopurine Tablets Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Dr. Reddy's Laboratories Mercaptopurine Tablets Product Portfolio Table 112. Dr. Reddy's Laboratories Recent Development Table 113. Key Raw Materials Table 114. Raw Materials Key Suppliers Table 115. Mercaptopurine Tablets Distributors List Table 116. Mercaptopurine Tablets Customers List Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. Mercaptopurine Tablets Product Image Figure 2. Global Mercaptopurine Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Mercaptopurine Tablets Market Size (2021-2032) & (US$ Million) Figure 4. Global Mercaptopurine Tablets Sales (2021-2032) & (k units) Figure 5. Global Mercaptopurine Tablets Average Price (USD/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Mercaptopurine Tablets Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 25mg Image Figure 9. 50mg Image Figure 10. Global Mercaptopurine Tablets Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Mercaptopurine Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Mercaptopurine Tablets Sales Market Share by Type (2021-2032) Figure 13. Global Mercaptopurine Tablets Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Mercaptopurine Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Mercaptopurine Tablets Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Clinic Image Figure 18. Others Image Figure 19. Global Mercaptopurine Tablets Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Mercaptopurine Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Mercaptopurine Tablets Sales Market Share by Application (2021-2032) Figure 22. Global Mercaptopurine Tablets Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Mercaptopurine Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Mercaptopurine Tablets Revenue Market Share by Application (2021-2032) Figure 25. North America Mercaptopurine Tablets Sales and Growth Rate (2021-2032) & (k units) Figure 26. North America Mercaptopurine Tablets Sales Market Share by Country (2021-2032) Figure 27. U.S. Mercaptopurine Tablets Sales and Growth Rate (2021-2032) & (k units) Figure 28. Canada Mercaptopurine Tablets Sales and Growth Rate (2021-2032) & (k units) Figure 29. Mexico Mercaptopurine Tablets Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Mercaptopurine Tablets Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Mercaptopurine Tablets Sales Market Share by Country (2021-2032) Figure 32. Germany Mercaptopurine Tablets Sales and Growth Rate (2021-2032) & (k units) Figure 33. France Mercaptopurine Tablets Sales and Growth Rate (2021-2032) & (k units) Figure 34. U.K. Mercaptopurine Tablets Sales and Growth Rate (2021-2032) & (k units) Figure 35. Italy Mercaptopurine Tablets Sales and Growth Rate (2021-2032) & (k units) Figure 36. Netherlands Mercaptopurine Tablets Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Mercaptopurine Tablets Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Mercaptopurine Tablets Sales Market Share by Country (2021-2032) Figure 39. China Mercaptopurine Tablets Sales and Growth Rate (2021-2032) & (k units) Figure 40. Japan Mercaptopurine Tablets Sales and Growth Rate (2021-2032) & (k units) Figure 41. South Korea Mercaptopurine Tablets Sales and Growth Rate (2021-2032) & (k units) Figure 42. Southeast Asia Mercaptopurine Tablets Sales and Growth Rate (2021-2032) & (k units) Figure 43. India Mercaptopurine Tablets Sales and Growth Rate (2021-2032) & (k units) Figure 44. Australia Mercaptopurine Tablets Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Mercaptopurine Tablets Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Mercaptopurine Tablets Sales Market Share by Country (2021-2032) Figure 47. Brazil Mercaptopurine Tablets Sales and Growth Rate (2021-2032) & (k units) Figure 48. South Africa Mercaptopurine Tablets Sales and Growth Rate (2021-2032) & (k units) Figure 49. Saudi Arabia Mercaptopurine Tablets Sales and Growth Rate (2021-2032) & (k units) Figure 50. Turkey Mercaptopurine Tablets Sales and Growth Rate (2021-2032) & (k units) Figure 51. Argentina Mercaptopurine Tablets Sales and Growth Rate (2021-2032) & (k units) Figure 52. UAE Mercaptopurine Tablets Sales and Growth Rate (2021-2032) & (k units) Figure 53. Egypt Mercaptopurine Tablets Sales and Growth Rate (2021-2032) & (k units) Figure 54. Chile Mercaptopurine Tablets Sales and Growth Rate (2021-2032) & (k units) Figure 55. Global Mercaptopurine Tablets Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Mercaptopurine Tablets Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Mercaptopurine Tablets Revenue (2021-2032) & (US$ Million) Figure 58. North America Mercaptopurine Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Mercaptopurine Tablets Revenue (2021-2032) & (US$ Million) Figure 60. Europe Mercaptopurine Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Mercaptopurine Tablets Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Mercaptopurine Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Mercaptopurine Tablets Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Mercaptopurine Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Mercaptopurine Tablets Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Mercaptopurine Tablets Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • 25mg
  • 50mg
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Zhejiang Zhebei Pharmaceutical
  • Sinopharm
  • Shaanxi Hantang Pharmaceutical
  • China Resources Double-Crane Pharmaceutical
  • Zhejiang Hisun Pharmaceutical
  • Guangzhou Baiyunshan Guanghua Pharmaceutical
  • Viatris
  • Stason Pharmaceuticals
  • Hikma Pharmaceuticals
  • Dr. Reddy's Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Mercaptopurine Tablets Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Mercaptopurine Tablets Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Mercaptopurine Tablets Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Mercaptopurine Tablets Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Mercaptopurine Tablets Market Dynamics
  1. 2.1 Mercaptopurine Tablets Industry Trends
  2. 2.2 Mercaptopurine Tablets Industry Drivers
  3. 2.3 Mercaptopurine Tablets Industry Opportunities and Challenges
  4. 2.4 Mercaptopurine Tablets Industry Restraints
3 Mercaptopurine Tablets Market by Manufacturers
  1. 3.1 Global Mercaptopurine Tablets Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Mercaptopurine Tablets Sales by Manufacturers (2021-2026)
  3. 3.3 Global Mercaptopurine Tablets Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Mercaptopurine Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Mercaptopurine Tablets Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Mercaptopurine Tablets Manufacturers, Product Type & Application
  7. 3.7 Global Mercaptopurine Tablets Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Mercaptopurine Tablets Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Mercaptopurine Tablets Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Mercaptopurine Tablets Tier 1, Tier 2, and Tier 3
4 Mercaptopurine Tablets Market by Type
  1. 4.1 Mercaptopurine Tablets Type Introduction
  2. 4.1.1 25mg
  3. 4.1.2 50mg
  4. 4.2 Global Mercaptopurine Tablets Sales by Type
  5. 4.2.1 Global Mercaptopurine Tablets Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Mercaptopurine Tablets Sales by Type (2021-2032)
  7. 4.2.3 Global Mercaptopurine Tablets Sales Market Share by Type (2021-2032)
  8. 4.3 Global Mercaptopurine Tablets Revenue by Type
  9. 4.3.1 Global Mercaptopurine Tablets Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Mercaptopurine Tablets Revenue by Type (2021-2032)
  11. 4.3.3 Global Mercaptopurine Tablets Revenue Market Share by Type (2021-2032)
5 Mercaptopurine Tablets Market by Application
  1. 5.1 Mercaptopurine Tablets Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Mercaptopurine Tablets Sales by Application
  6. 5.2.1 Global Mercaptopurine Tablets Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Mercaptopurine Tablets Sales by Application (2021-2032)
  8. 5.2.3 Global Mercaptopurine Tablets Sales Market Share by Application (2021-2032)
  9. 5.3 Global Mercaptopurine Tablets Revenue by Application
  10. 5.3.1 Global Mercaptopurine Tablets Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Mercaptopurine Tablets Revenue by Application (2021-2032)
  12. 5.3.3 Global Mercaptopurine Tablets Revenue Market Share by Application (2021-2032)
6 Global Mercaptopurine Tablets Sales by Region
  1. 6.1 Global Mercaptopurine Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Mercaptopurine Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Mercaptopurine Tablets Sales by Region (2021-2026)
  4. 6.2.2 Global Mercaptopurine Tablets Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Mercaptopurine Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Mercaptopurine Tablets Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Mercaptopurine Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Mercaptopurine Tablets Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Mercaptopurine Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Mercaptopurine Tablets Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Mercaptopurine Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Mercaptopurine Tablets Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Mercaptopurine Tablets Revenue by Region
  1. 7.1 Global Mercaptopurine Tablets Revenue by Region
  2. 7.1.1 Global Mercaptopurine Tablets Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Mercaptopurine Tablets Revenue by Region (2021-2026)
  4. 7.1.3 Global Mercaptopurine Tablets Revenue by Region (2027-2032)
  5. 7.1.4 Global Mercaptopurine Tablets Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Mercaptopurine Tablets Revenue (2021-2032)
  8. 7.2.2 North America Mercaptopurine Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Mercaptopurine Tablets Revenue (2021-2032)
  11. 7.3.2 Europe Mercaptopurine Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Mercaptopurine Tablets Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Mercaptopurine Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Mercaptopurine Tablets Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Mercaptopurine Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Zhejiang Zhebei Pharmaceutical
  2. 8.1.1 Zhejiang Zhebei Pharmaceutical Company Information
  3. 8.1.2 Zhejiang Zhebei Pharmaceutical Business Overview
  4. 8.1.3 Zhejiang Zhebei Pharmaceutical Mercaptopurine Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Zhejiang Zhebei Pharmaceutical Mercaptopurine Tablets Product Portfolio
  6. 8.1.5 Zhejiang Zhebei Pharmaceutical Recent Developments
  7. 8.2 Sinopharm
  8. 8.2.1 Sinopharm Company Information
  9. 8.2.2 Sinopharm Business Overview
  10. 8.2.3 Sinopharm Mercaptopurine Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sinopharm Mercaptopurine Tablets Product Portfolio
  12. 8.2.5 Sinopharm Recent Developments
  13. 8.3 Shaanxi Hantang Pharmaceutical
  14. 8.3.1 Shaanxi Hantang Pharmaceutical Company Information
  15. 8.3.2 Shaanxi Hantang Pharmaceutical Business Overview
  16. 8.3.3 Shaanxi Hantang Pharmaceutical Mercaptopurine Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Shaanxi Hantang Pharmaceutical Mercaptopurine Tablets Product Portfolio
  18. 8.3.5 Shaanxi Hantang Pharmaceutical Recent Developments
  19. 8.4 China Resources Double-Crane Pharmaceutical
  20. 8.4.1 China Resources Double-Crane Pharmaceutical Company Information
  21. 8.4.2 China Resources Double-Crane Pharmaceutical Business Overview
  22. 8.4.3 China Resources Double-Crane Pharmaceutical Mercaptopurine Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 China Resources Double-Crane Pharmaceutical Mercaptopurine Tablets Product Portfolio
  24. 8.4.5 China Resources Double-Crane Pharmaceutical Recent Developments
  25. 8.5 Zhejiang Hisun Pharmaceutical
  26. 8.5.1 Zhejiang Hisun Pharmaceutical Company Information
  27. 8.5.2 Zhejiang Hisun Pharmaceutical Business Overview
  28. 8.5.3 Zhejiang Hisun Pharmaceutical Mercaptopurine Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Zhejiang Hisun Pharmaceutical Mercaptopurine Tablets Product Portfolio
  30. 8.5.5 Zhejiang Hisun Pharmaceutical Recent Developments
  31. 8.6 Guangzhou Baiyunshan Guanghua Pharmaceutical
  32. 8.6.1 Guangzhou Baiyunshan Guanghua Pharmaceutical Company Information
  33. 8.6.2 Guangzhou Baiyunshan Guanghua Pharmaceutical Business Overview
  34. 8.6.3 Guangzhou Baiyunshan Guanghua Pharmaceutical Mercaptopurine Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Guangzhou Baiyunshan Guanghua Pharmaceutical Mercaptopurine Tablets Product Portfolio
  36. 8.6.5 Guangzhou Baiyunshan Guanghua Pharmaceutical Recent Developments
  37. 8.7 Viatris
  38. 8.7.1 Viatris Company Information
  39. 8.7.2 Viatris Business Overview
  40. 8.7.3 Viatris Mercaptopurine Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Viatris Mercaptopurine Tablets Product Portfolio
  42. 8.7.5 Viatris Recent Developments
  43. 8.8 Stason Pharmaceuticals
  44. 8.8.1 Stason Pharmaceuticals Company Information
  45. 8.8.2 Stason Pharmaceuticals Business Overview
  46. 8.8.3 Stason Pharmaceuticals Mercaptopurine Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Stason Pharmaceuticals Mercaptopurine Tablets Product Portfolio
  48. 8.8.5 Stason Pharmaceuticals Recent Developments
  49. 8.9 Hikma Pharmaceuticals
  50. 8.9.1 Hikma Pharmaceuticals Company Information
  51. 8.9.2 Hikma Pharmaceuticals Business Overview
  52. 8.9.3 Hikma Pharmaceuticals Mercaptopurine Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Hikma Pharmaceuticals Mercaptopurine Tablets Product Portfolio
  54. 8.9.5 Hikma Pharmaceuticals Recent Developments
  55. 8.10 Dr. Reddy's Laboratories
  56. 8.10.1 Dr. Reddy's Laboratories Company Information
  57. 8.10.2 Dr. Reddy's Laboratories Business Overview
  58. 8.10.3 Dr. Reddy's Laboratories Mercaptopurine Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Dr. Reddy's Laboratories Mercaptopurine Tablets Product Portfolio
  60. 8.10.5 Dr. Reddy's Laboratories Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Mercaptopurine Tablets Value Chain Analysis
  2. 9.1.1 Mercaptopurine Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Mercaptopurine Tablets Production Mode & Process
  6. 9.2 Mercaptopurine Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Mercaptopurine Tablets Distributors
  9. 9.2.3 Mercaptopurine Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst